Cargando…
Identification of a Novel Oncogenic Fusion Gene SPON1-TRIM29 in Clinical Ovarian Cancer That Promotes Cell and Tumor Growth and Enhances Chemoresistance in A2780 Cells
Gene structure alterations, such as chromosomal rearrangements that develop fusion genes, often contribute to tumorigenesis. It has been shown that the fusion genes identified in public RNA-sequencing datasets are mainly derived from intrachromosomal rearrangements. In this study, we explored fusion...
Autores principales: | Nagasawa, Saya, Ikeda, Kazuhiro, Shintani, Daisuke, Yang, Chiujung, Takeda, Satoru, Hasegawa, Kosei, Horie, Kuniko, Inoue, Satoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776205/ https://www.ncbi.nlm.nih.gov/pubmed/35054873 http://dx.doi.org/10.3390/ijms23020689 |
Ejemplares similares
-
Systematic Identification of Characteristic Genes of Ovarian Clear Cell Carcinoma Compared with High-Grade Serous Carcinoma Based on RNA-Sequencing
por: Nagasawa, Saya, et al.
Publicado: (2019) -
Testis-expressed gene 11 inhibits cisplatin-induced DNA damage and contributes to chemoresistance in testicular germ cell tumor
por: Kitayama, Sachi, et al.
Publicado: (2022) -
Comprehensive analysis of the oncogenic and immunological role of SPON2 in human tumors
por: Tang, Jiali, et al.
Publicado: (2023) -
MON-310 Oncogenic Roles of Tripartite Motif 25 in Endometrial Cancer
por: Horie-Inoue, Kuniko, et al.
Publicado: (2019) -
Long Intergenic Noncoding RNA OIN1 Promotes Ovarian Cancer Growth by Modulating Apoptosis-Related Gene Expression
por: Takeiwa, Toshihiko, et al.
Publicado: (2021)